Total Payments
$43,726
2024 Payments
$17,311
Companies
34
Transactions
159
Medicare Patients
4,437
Medicare Billing
$541,622
Payment Breakdown by Category
Consulting$21,010 (48.0%)
Other$19,678 (45.0%)
Food & Beverage$2,617 (6.0%)
Travel$397.00 (0.9%)
Education$24.21 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,010 | 23 | 48.0% |
| Honoraria | $19,678 | 26 | 45.0% |
| Food and Beverage | $2,617 | 102 | 6.0% |
| Travel and Lodging | $397.00 | 1 | 0.9% |
| Education | $24.21 | 2 | 0.1% |
| Unspecified | $0 | 5 | 0.0% |
Payments by Type
General
$43,726
154 transactions
Ownership
$0
5 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Cornerstone Specialty Network LLC | $18,514 | 30 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $8,878 | 17 | $0 (2024) |
| Daiichi Sankyo Inc. | $5,883 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,016 | 8 | $0 (2024) |
| GENZYME CORPORATION | $2,312 | 4 | $0 (2024) |
| PFIZER INC. | $1,438 | 12 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $764.75 | 1 | $0 (2022) |
| BeiGene USA, Inc. | $699.23 | 3 | $0 (2024) |
| Verity Pharmaceuticals Inc. | $500.00 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $222.83 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17,311 | 60 | AstraZeneca Pharmaceuticals LP ($8,798) |
| 2023 | $16,416 | 49 | Cornerstone Specialty Network LLC ($9,089) |
| 2022 | $9,596 | 35 | Cornerstone Specialty Network LLC ($7,875) |
| 2021 | $128.07 | 8 | Lilly USA, LLC ($30.04) |
| 2020 | $32.02 | 2 | E.R. Squibb & Sons, L.L.C. ($16.89) |
| 2019 | $121.02 | 3 | Janssen Biotech, Inc. ($81.91) |
| 2018 | $121.94 | 2 | Seattle Genetics, Inc. ($121.94) |
All Payment Transactions
159 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: ONCOLOGY | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | Truqap (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 11/26/2024 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $675.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: ONCOLOGY | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Oncology | ||||||
| 11/04/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $33.13 | General |
| Category: Immunology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/25/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $17.36 | General |
| Category: ONCOLOGY | ||||||
| 10/25/2024 | PFIZER INC. | INLYTA (Drug), PADCEV | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $1.83 | General |
| Category: ONCOLOGY | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | JEMPERLI (Biological), ZEJULA | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: ONCOLOGY | ||||||
| 09/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $26.60 | General |
| Category: Immunology | ||||||
| 09/12/2024 | SOBI, INC | VONJO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 09/12/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.19 | General |
| 08/30/2024 | Pharmacosmos Therapeutics Inc. | MONOFERRIC (Drug) | Food and Beverage | In-kind items and services | $19.07 | General |
| Category: HEMATOLOGY | ||||||
| 08/28/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 08/08/2024 | Genmab U.S., Inc. | Epkinly (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Oncology | ||||||
| 07/31/2024 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Prostate cancer | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 34 | 1,270 | 36,451 | $493,977 | $144,569 |
| 2022 | 36 | 1,395 | 14,119 | $448,818 | $172,634 |
| 2021 | 30 | 1,056 | 15,486 | $379,409 | $144,874 |
| 2020 | 26 | 716 | 2,376 | $204,010 | $79,545 |
Total Patients
4,437
Total Services
68,432
Medicare Billing
$541,622
Procedure Codes
126
All Medicare Procedures & Services
126 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 290 | $53,360 | $26,583 | 49.8% |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | Office | 2023 | 12 | 3,600 | $43,200 | $16,418 | 38.0% |
| J1439 | Injection, ferric carboxymaltose, 1 mg | Office | 2023 | 17 | 17,250 | $47,438 | $15,123 | 31.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 37 | 114 | $39,900 | $10,987 | 27.5% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 12 | 4,540 | $68,100 | $10,629 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 87 | 132 | $16,500 | $7,798 | 47.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 44 | 44 | $15,576 | $7,040 | 45.2% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 17 | 29 | $18,675 | $6,693 | 35.8% |
| J0185 | Injection, aprepitant, 1 mg | Office | 2023 | 12 | 4,550 | $27,300 | $6,097 | 22.3% |
| 96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 93 | $16,275 | $4,997 | 30.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 164 | 426 | $24,708 | $4,409 | 17.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 193 | 512 | $17,920 | $3,896 | 21.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 21 | 22 | $5,456 | $2,988 | 54.8% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 28 | 124 | $9,424 | $2,632 | 27.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 35 | 56 | $7,840 | $2,516 | 32.1% |
| 71260 | Ct scan of chest with contrast | Office | 2023 | 19 | 32 | $19,200 | $2,506 | 13.1% |
| 96417 | Administration of additional new drug or substance into vein, 1 hour or less | Office | 2023 | 11 | 41 | $7,380 | $1,951 | 26.4% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $4,200 | $1,592 | 37.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 45 | 147 | $6,468 | $1,515 | 23.4% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 16 | 66 | $5,940 | $1,386 | 23.3% |
| 83521 | Measurement of immunoglobulin light chains | Office | 2023 | 20 | 70 | $3,010 | $1,185 | 39.4% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 52 | 77 | $4,312 | $1,029 | 23.9% |
| 82784 | Gammaglobulin (immune system protein) measurement | Office | 2023 | 22 | 93 | $3,720 | $847.23 | 22.8% |
| 84165 | Protein measurement, serum | Office | 2023 | 26 | 53 | $3,180 | $558.09 | 17.6% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 32 | 36 | $2,232 | $532.08 | 23.8% |
About Dr. Robert Havard, M.D
Dr. Robert Havard, M.D is a Internal Medicine healthcare provider based in Salt Lake City, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/16/2013. The National Provider Identifier (NPI) number assigned to this provider is 1144663493.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Havard, M.D has received a total of $43,726 in payments from pharmaceutical and medical device companies, with $17,311 received in 2024. These payments were reported across 159 transactions from 34 companies. The most common payment nature is "Consulting Fee" ($21,010).
As a Medicare-enrolled provider, Havard has provided services to 4,437 Medicare beneficiaries, totaling 68,432 services with total Medicare billing of $541,622. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology, Hematology & Oncology
- Location Salt Lake City, UT
- Active Since 04/16/2013
- Last Updated 06/04/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144663493
Products in Payments
- IMFINZI (Biological) $3,741
- Enhertu (Drug) $3,686
- LYNPARZA (Drug) $2,345
- PADCEV (Biological) $1,217
- Stivarga (Drug) $764.75
- BRUKINSA (Drug) $699.23
- ENHERTU (Drug) $587.50
- TAGRISSO (Drug) $548.89
- CALQUENCE (Drug) $525.00
- Truqap (Drug) $525.00
- Trelstar (Drug) $500.00
- LIBTAYO (Biological) $222.83
- VONJO (Drug) $200.00
- ADCETRIS (Biological) $175.40
- DARZALEX (Biological) $126.68
- OPDIVO (Biological) $99.20
- TALZENNA (Drug) $89.47
- CYRAMZA (Drug) $85.17
- Fabhalta (Drug) $81.73
- JEMPERLI (Biological) $56.06
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Salt Lake City
Dr. Willard Dere, M.d, M.D
Internal Medicine — Payments: $5.4M
Internal Medicine $5.4M
Dr. Catherine Bakewell, M.d, M.D
Internal Medicine — Payments: $1.0M
Internal Medicine $1.0M
Dr. April Erwin, Md, MD
Internal Medicine — Payments: $381,757
Internal Medicine $381,757
Dr. Neeraj Agarwal, Md, MD
Internal Medicine — Payments: $344,790
Internal Medicine $344,790
George Rodgers, M.d, M.D
Internal Medicine — Payments: $229,629
Internal Medicine $229,629
James Chamberlain, Md, MD
Internal Medicine — Payments: $200,257
Internal Medicine $200,257